Alferez, Jelly A.

HRN: 23-26-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
CEFUROXIME 1.5GM (VIAL)
07/10/2023
07/10/2023
IV
1.5gm
Prior To OR
For Stat CS
Waiting Final Action 
07/11/2023
CEFUROXIME 500MG (TAB)
07/11/2023
07/17/2023
PO
500mg
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: